Free Trial

ViewRay (VRAYQ) Competitors

VRAYQ vs. BRSH, SDCCQ, GMVDF, AHPI, AFIB, NMRD, MOTS, UTRS, VIVE, and DRTSW

Should you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Acutus Medical (AFIB), Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Viveve Medical (VIVE), and Alpha Tau Medical (DRTSW). These companies are all part of the "medical equipment" industry.

ViewRay vs. Its Competitors

Bruush Oral Care (NASDAQ:BRSH) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

In the previous week, Bruush Oral Care's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
Bruush Oral Care Neutral
ViewRay Neutral

Bruush Oral Care has higher earnings, but lower revenue than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bruush Oral Care$2.92M0.00N/AN/AN/A
ViewRay$102.21M0.00-$107.33MN/AN/A

31.9% of Bruush Oral Care shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 29.8% of Bruush Oral Care shares are held by company insiders. Comparatively, 2.5% of ViewRay shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Bruush Oral CareN/A N/A N/A
ViewRay N/A N/A N/A

Bruush Oral Care has a beta of 2.76, suggesting that its stock price is 176% more volatile than the S&P 500. Comparatively, ViewRay has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.

Summary

Bruush Oral Care beats ViewRay on 3 of the 4 factors compared between the two stocks.

Get ViewRay News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRAYQ vs. The Competition

MetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$18K$35.23M$5.57B$9.31B
Dividend YieldN/AN/A4.23%4.03%
P/E RatioN/A3.1228.6119.73
Price / SalesN/A233.71412.31173.11
Price / CashN/A41.3636.0257.96
Price / BookN/A1.998.235.67
Net Income-$107.33M-$2.66M$3.23B$257.79M

ViewRay Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21M0.00300
BRSH
Bruush Oral Care
N/AN/AN/AN/A$44K$2.92M0.0011Gap Down
SDCCQ
SmileDirectClub
N/AN/AN/A-97.5%$40K$470.74M0.002,700
GMVDF
G Medical Innovations
N/A$0.00
flat
N/A-98.6%$26K$4.42M0.0072
AHPI
Allied Healthcare Products
N/AN/AN/AN/A$16K$27.05M0.00150Gap Up
AFIB
Acutus Medical
N/A$0.00
-90.0%
N/A-92.7%$6K$7.16M0.00340News Coverage
Gap Down
High Trading Volume
NMRD
Nemaura Medical
1.156 of 5 stars
N/AN/A-99.7%$4K$3.02K0.0040
MOTS
Motus GI
N/A$0.00
flat
N/A-99.4%$2K$319K0.0030
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69M0.00160
VIVE
Viveve Medical
N/AN/AN/AN/A$1K$6.83M0.0070
DRTSW
Alpha Tau Medical
N/A$0.24
-14.5%
N/A+9.2%$0.00N/A0.0080

Related Companies and Tools


This page (NASDAQ:VRAYQ) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners